Drug Profile
Research programme: migraine prophylactic therapy - Sepracor
Alternative Names: SEP 225382Latest Information Update: 11 Jul 2007
Price :
$50
*
At a glance
- Originator Sepracor
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Migraine
Most Recent Events
- 15 Mar 2004 Preclinical trials in Migraine in USA (unspecified route)